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Abstract
Background: In recent years data from both mouse models and human tumors suggest that loss of one allele of
genes involved in DNA repair pathways may play a central role in genomic instability and carcinogenesis.
Additionally several examples in mouse models confirmed that loss of one allele of two functionally related genes
may have an additive effect on tumor development. To understand some of the mechanisms involved, we
examined the role of monoallelic loss or Atm and Brca1 on cell transformation and apoptosis induced by radiation.
Methods: Cell transformation and apoptosis were measured in mouse embryo fibroblasts (MEF) and thymocytes
respectively. Combinations of wild type and hemizygous genotypes for ATM and BRCA1 were tested in various
comparisons.
Results: Haploinsufficiency of either ATM or BRCA1 resulted in an increase in the incidence of radiation-induced
transformation of MEF and a corresponding decrease in the proportion of thymocytes dying an apoptotic death,
compared with cells from wild-type animals. Combined haploinsufficiency for both genes resulted in an even
larger effect on apoptosis.
Conclusions: Under stress, the efficiency and capacity for DNA repair mediated by the ATM/BRCA1 cell signalling
network depends on the expression levels of both proteins.
Background
In recent years data from both mouse models and
human tumors, suggest that loss of one allele of genes
involved in DNA repair pathways may play an important
role in carcinogenesis. Haploinsufficiency as a result of
loss of allele for APC, ARF, ATM, BRCA1, BRCA2,
LKB1, CDKN1B, P53, RB and other proteins has been
shown to contribute to tumorigenesis [1-6]. Addition-
ally, several examples in mouse models confirmed that
hemizygosity for functionally related genes may have an
additive effect on tumor development. Combined hemi-
zygosity for Xpc and p53, Atm and p53,a n dFen1 and
Apc genes predispose humans to UV radiation-induced
skin cancer, mammary carcinoma or adenocarcinomas,
respectively [7-9]. Importantly, hemizygous genotypes
did not contribute to tumor development alone, but if
combined with hemizygosity for another gene involved
in DNA repair, the contribution became significant. All
of this evidence suggested that tumorigenesis may
depend on the expression levels of single or combina-
tion of proteins. We have reported that primary mouse
cells haploinsufficient for either of two important DNA
repair proteins, Atm or Rad9, are more sensitive to
transformation by radiation and are less apoptotic when
compared with wild-type controls [10]. Furthermore,
cells doubly haploinsufficient for Atm and Rad9 showed
an even higher level of radiation-induced transformation
and an even lower level of apoptosis than those cells
haploinsufficient for either one of these proteins alone.
We now extend these studies to primary mouse cells
derived from animals hemizygous for Brca1 and Atm.
Earlier reports suggested a link between Atm heterozyg-
osity and breast cancer. The reported estimated relative
risk varied in the range of 1.5 to 12 fold [11-13]. Differ-
ent mechanisms by which ATM heterozygosity contri-
butes to breast cancer pathobiology were proposed,
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dominant negative ATM protein [14,15]. However a
large number of the detected ATM mutations in familial
breast cancer cases are actually result in truncated gene
products resulting in no expression of ATM protein
from the mutant allele [13]. The frequency of such
mutations is also very high (> 80%) in ATM patients
[16,17]. Importantly, the frequency of ATM heterozy-
gotes with null mutation for one of the alleles could be
as high as 1-3% of the US population [18,19]. Taken
together, these observations led us to investigate the
effects of monoallelic loss for two genes - ATM and
BRCA1 in primary cells for two endpoints: cell transfor-
mation and cell apoptosis. Cells matching these criteria
were derived from established Atm and Brca1 heterozy-
gous parental strains of mice. In both parental strains,
o n eo ft h ea l l e l e so ft h eAtm or Brca1 genes was trun-
cated, resulting in loss of expression of the correspond-
ing protein from the truncated allele. The biological
function and roles of ATM and BRCA1 are relatively
well established. Both proteins are involved in DNA
repair and function as sensor/transducers. ATM is
involved in the earliest events in DNA double strand
break detection and initiates the activation of several
pathways linked to cell cycle checkpoint controls [20].
ATM also recruits DNA repair proteins to sites of DNA
damage and, along with BRCA1 is part of supramolecu-
lar DNA repair complex comprised of many factors
[21]. The phosphorylation of BRCA1 by ATM is an
important event in the activation of the S/G2 and G2/M
checkpoints [22]. BRCA1 likely plays multiple roles in
the mechanisms of physical repair of DNA [23,24].
Mutations of either protein are associated with tumor
development. ATM deficiency results in lymphoid
malignancies and BRCA1 mutation carriers have 50-85%
life risk of developing breast cancer [25]. We hypothe-
size that the appropriate function of signaling networks
that facilitate either DNA damage repair, cell signaling,
or programmed cell death, depends on the expression
levels of key proteins. Consequently, hemizygosity caus-
ing haploinsufficiency may create conditions where net-
work efficiency is reduced leading to decreased
effectiveness of DNA repair. In this study we show that
hemizygosity for either Atm or Brca1 or both increases
the incidence of cell transformation and decreases apop-
tosis. Remarkably, cells hemizygous for both genes show
the lowest levels of radiation-induced apoptosis.
Methods
Mice
Atm and Brca1 heterozygous (+/-) animals have been
described previously [26,27]. In both mouse models
one of the Atm or Brca1 alleles have been disrupted
by targeted mutagenesis. This mutagenesis prevented
any protein synthesis from the targeted alleles. As a
result, Atm or BRCA1 proteins were coded only from
the wild type alleles. Atm and Brca1 hemizygous mice
were mated and only F1 littermates were used. Geno-
types were determined by PCR. The p53 status was
“wild type” for both genotypes as shown earlier
[27,28]
Embryo Cell Preparation
Pregnant mice were sacrificed on day 14 of the gesta-
tion. Mouse embryo fibroblasts (MEF) from each
embryo were cultured separately with DMEM high glu-
cose (Invitrogen) supplemented with 15% FBS (ATCC)
and then genotyped. Four genotypes of MEF cells from
the same litter were used for each experiment: wild-
type, (Atmwt/Brca1wt), single hemizygous (hz) for Atm
(Atmhz/Brca1wt) single hemizygous for Brca1 (Atmwt/
Brca1hz) and double hemizygous (Atmhz/Brca1hz).
Cell Transformation Assay
Exponentially growing MEFs received a dose of 2 Gy of
g-rays in an acute exposure, and controls were sham-
irradiated. MEFs were then plated in 10 cm plates at a
density of 6,000 cells/plate over a feeder layer of 70,000
cells prepared from the same embryo but irradiated pre-
viously with a supralethal dose of 30 Gy. After 2 weeks
of growth in DMEM medium supplemented with 10%
fetal bovine serum at 37°C in a 5% CO2 air-humidified
incubator, cells were fixed, stained, and yields of trans-
formed clones scored. The scoring criteria was devel-
oped and examined by preliminary experiments, where
embryo cells were irradiated and plated at the same
density. The clones which seemed dense and had stel-
late-shaped piled cells were photographed and isolated
with cloning cylinders. These clones were expanded and
injected into nude mice. Those that caused the develop-
ment of subcutaneous tumors were designated as trans-
formed. Clones that matched their shape and
dimensions were scored as transformed in later experi-
ments. Plating efficiency, cell surviving fractions, and the
spontaneous and radiation-induced frequency of trans-
formation were determined.
Evaluation of micronuclei
Exponentially growing MEF cells were plated at density
of 50,000 cells/well of 12-well plate. Next day, the cells
were exposed to various doses of g-rays. Immediately
after irradiation, 1.5 μg/ml of cytochalasin B (Sigma)
was added to each well. 24 hours later, the cells were
fixed with acetic acid and methanol (v/v = 3:1), and
stained with 3 μg/ml of acridine orange (Sigma) for 1
min. Micronuclei in binucleated cells (BN) were counted
under fluorescent microscope. More than 500 BN cells
were scored for each sample.
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Mice were irradiated with 5 Gy of g-rays. 24 hours later,
thymuses from the irradiated and sham-irradiated con-
trol mice were isolated, weighed and homogenized
gently for single cell suspension preparation. After esti-
mation of the total cell number, 1× 10
6 cells from each
genotype were labeled with CD
4+ and CD
8+ specific
antibodies (Pharmingen) and two color flow cytometry
analysis was used to estimate the survival of each thy-
mocyte subtype. Total of 20,000 cells for each genotype
were examined and the percent of double positive CD
4
+/CD
8+ cells was estimated based on that number.
Comet Assay
DNA damage and repair were evaluated with alkaline
comet assay according to the report by Olive et al [29]
with some modifications. Single MEF cells were har-
vested by trypsin treatment and resuspended in DMEM
containing 10% FBS at a concentration of 1×10
6 cells/
ml. An aliquot of 100 μl cell suspension was mixed with
300 μl 0.5% low melting-point agarose (Amresco) in
DMEM containing 10% FBS. 100 μlo ft h em i x t u r ew a s
layered on glass slide pre-coated with 0.5% LE agarose
and covered with another glass slide. After brief incuba-
tion on ice for agarose solidification, the cover slides
were carefully removed and the samples were gently
immersed into freshly prepared lysis solution (2.5 M
NaCl, 10 mM Tris, 1% sodium lauryl sarcosinate, 100
mM EDTA, 1% Triton-100, and 10% DMSO) for 1.5 hrs
followed by incubation for 20 min in electrophoresis
buffer (1 mM EDTA, 300 mM NaOH, pH > 13). The
electrophoresis was performed in the same buffer (20
min, 20 V, 300 mA). The samples were neutralized with
0.4 M Tris-HCl buffer (pH 7.5) and air-dried after a
brief fixation with 70% ethanol.
Individual cells were visualized with BrdU staining and
photographed under fluorescence microscope. 100
comets of each sample were analyzed with a free soft-
ware called Casp [30].
Results
Cell Transformation Assay
Radiation-induced transformation of MEF was examined
as a surrogate for carcinogenesis in vivo. A total of 19
embryos from five litters were used and included the fol-
lowing genotypes: Atmwt/Brca1wt, Atmwt/Brca1hz,
Atmhz/Brca1w ta n dAtmhz/Brca1hz. Yields of trans-
formed clones were measured both for unexposed controls
and after a dose of 2 Gy. The results shown in Tables 1
and 2 indicate a statistically significant increase in trans-
formation frequency for the single and doubly hemizygous
cells. Transformation frequencies for these cells were
nearly two times higher than the one of wild-type cells.
Brca1 hemizygotes show a similar transformation
frequency as the Atm hz, however, the interesting point to
note is that the double hemizygotes Atm/Brca1,s h o wl i t t l e
or no increase over Brca1hz or Atm hz alone. There were
small statistically not significant differences in the clono-
genic survival for all populations after irradiation (results
not shown).
Background DNA damage estimation in the different
genotypes
In these experiments we accessed the background DNA
damage in all four genotypes by alkaline comet assay
(Figure 1). Notably there were statistically significant dif-
ferences in the tail moments between the wild type and
all hemizygous genotypes. These differences illustrate
that cells that are singly or doubly hemizygous for Atm
and Brca1 have more background DNA damage than
wild type cells. This elevated background of DNA
damage may point to the higher vulnerability of these
cells to DNA damage and cell transformation if addi-
tional damage is induced.
Micronucleus Assay
Figure 2 shows the data for micronuclei, scored in binu-
cleated cells, 24 hours after exposure to graded doses of
0.5 to 3 Gy of g-rays. There was a statistically significant
increase of micronuclei in cells hemizygous for both
Atm and Brca1 at the highest dose, but for lower doses
no such differences were found. These results suggests
that the DNA damage induced by radiation is less effi-
ciently repaired in double hemizygous cells and may
point to an increased mutation accumulation in these
cells after DNA damage is induced.
Apoptosis of Thymocytes
We examined the survival of the most numerous type of
cells in the thymus (more than 80% of all cells), CD4
+/CD8
+ thymocytes, after in vivo g-irradiation (Figure 3).
As expected, 24 hrs after irradiation the numbers of
CD4
+/CD8
+ cells were significantly reduced. The survi-
val of CD4
+/CD8
+ cells from single Atm hemizygous
mice was 10% higher than the wild type controls. Inter-
estingly, the survival of Brca1 hemizygous thymocytes
trends similarly. However, compared with the other
three genotypes, the survival of the double hemizygous
thymocytes was significantly higher. More than 40% of
these thymocytes survived which shows that they are
more resistant to radiation and less apoptotic than the
other genotypes examined. This implies that Atm/Brca1
cells may accumulate mutations at a higher rate than
the other genotypes.
Discussion
This study demonstrates that cells hemizygous for either
Atm or Brca1 are more sensitive to transformation by
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under stress. Remarkably, combined hemizygosity for
both genes show additive negative effect on apoptosis
induction and increased genomic instability reflected by
micronuclei formation.
In recent years, epidemiological data as well as studies
in mouse models confirmed that heterozygosity may
play a significant role in tumor initiation and develop-
ment. The most striking conclusion from these experi-
ments is that heterozygosity for a single gene may
contribute to tumor formation. To what degree this may
reflect in increased cancer risk heterozygous carriers is a
very important issue which can be resolved only after
understanding the mechanisms underlying the role of
heterozygosity in tumor formation. The role of hetero-
zygosity is more obvious in cases where the product of
the mutant allele is a truncated protein having dominant
negative effect. Truncated versions of P53, Rb, Ras, NF1,
ATM, BRCA1 and 2, INK4 family of proteins, CREB
binding protein (CBP) and others have been identified
in different tumors [31,32]. Much more difficult to
explain are the instances where the mutant allele does
not produce any protein. Cumulative data acquired in
c a s e sw h e r et h er o l eo fh e t erozygosity of a gene (one
allele inactivated, no protein expression from it) was
studied in mouse models, show that more than twenty
genes could be implicated in tumor development [33].
As u b s e to ft h e s e2 0g e n e si si n c l u d e di nt h eg r o u po f
the 300 known cancer genes [34]. Many of these genes
maintained their hemizygous status in the tumors that
developed as a result of their hemizygosity. In general,
t h eo n l yd i f f e r e n c eb e t w e e nt h ew i l dt y p ea n dh e m i z y -
gous status of these genes was the haploinsufficiency for
the corresponding protein.
We hypothesize that haploinsufficiency is a factor
mostly in acute cell conditions, where different factors
trigger stress response pathways. Due to the networked
nature of this response, the insufficient expression level
(s) of some proteins may lead to reduced overall
Table 1 Transformation frequencies of unirradiated or irradiated cells differing in the status of Atm and Brca1.
Genotype Dose (Gy) Total number of clones scored Number of transformed clones Transformed
clones (%)
Atmwt/Brca1wt 0 Gy 31220 7 0.02
2 Gy 21880 26 0.12
Atmwt/Brca1hz 0 Gy 34380 11 0.03
2 Gy 17142 32 0.19
Atmhz/Brca1wt 0 Gy 34170 11 0.03
2 Gy 16720 36 0.21
Atmhz/Brca1hz 0 Gy 26660 9 0.04
2 Gy 12046 27 0.22
Table 2 Comparisons of radiation induced transformation











t-test P = 0.03 P = 0.05 P = 0.018
Relative transformation is defined as the ratio of the number of transformed
clones per surviving hemizygous cells relative to the number of transformed
clones per surviving wild type cells. The statistical significance of differences
in transformation frequency between the various cells with hemizygous























Figure 1 DNA damage measured with alkaline comet assay.
Total DNA damage measured with alkaline comet assay points to
the higher background DNA damage in the hemizygous genotypes.
The data is from three independent experiments where total of 100
cells/genotype were scored.
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cesses, apoptosis for example, may be less effective. Pre-
viously, we substantiated this idea using a system where
both Atm and Rad9 genes were haploinsufficient [10].
I nt h ec u r r e n ts t u d yw eu s e da n o t h e rp a i ro fD N A
repair genes - Atm and Brca1.A sw a st h ec a s ei no u r
prior study, the background transformation frequency of
MEF was the same for all studied genotypes. Remark-
ably, the transformation frequency after induced DNA
damage was dependant on the genetic background. Both
hemizygous genotypes show statistically significant
increases in cell transformation in comparison with the
wild type cells. Interestingly, the transformation fre-
quency of MEF on a doubly hemizygous background
was in the same range as the singly hemizygous MEF
which indicated that there is no additive effect of hemi-
zygosity for Atm and Brca1 genes for this endpoint.
Nevertheless, these results confirm that stress related
pathways may depend on proper expression levels of
these key proteins.
The induction of genomic instability was monitored
by measuring micronuclei (MN) formation. In one set
of experiments, we determined the induction of MN in
different genotypes. Our results show that combined
hemizygosity for Atm and Brca1 genes results in ele-
vated levels of MN. This observation supports the con-
clusion from the transformation experiments and
indicated strongly that processes active under stress
depend on the expression levels of both Atm and Brca1
proteins.
The induction of cell transformation is thought to
depend on the efficiency of apoptosis induction. In
order to estimate the role of genetic background in
apoptosis induction, and since ATM plays very impor-
tant role in thymocyte apoptosis after irradiation [35],
we measured the survival of thymocytes in vivo after
radiation induced DNA damage. Under the conditions
we used, cell survival depended largely on the genetic
background. We registered the highest level of cell sur-
vival in the doubly hemizygous cells, where the rates
were two fold greater in wild type cells and 1.5 fold
greater than singly hemizygous cells. Since statistically,
the number of damaged sites per cells should be the
same for all genotypes, the differences in cell survival
suggests that damage detection was less efficient in the
double heterozygous cells and that more cells with DNA
Figure 2 Induction of micronuclei by graded doses of radiation. Induction of micronuclei by graded doses of radiation in mouse embryo
fibroblasts having different genetic backgrounds. Data are shown as a mean and standard error from 3 independent experiments. At a dose of
3G yo fg-rays, there is a statistically significant difference between the double hemizygous and the other genotypes.
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erozygous animals. Many if these cells will undergo
apoptosis in subsequent division attempts but a very
small fraction may survive increasing the probability of
subsequent transformation.
The results from the estimation of the background
DNA damage done by alkaline comet assay were some-
what unexpected for us. They clearly show that the
background DNA damage is higher in the hemizygous
g e n o t y p e s .S i n c ew ed i d n ’tf i n dd i f f e r e n c ei nt h eb a c k -
ground transformation frequency (and apoptosis,
although apoptosis was measured in different cell type)
between the heterozygous and wild type genotypes, we
may conclude that the DNA damage detected by this
method is not relevant to the background transforma-
tion frequency. It could be related though to the highest
transformation levels in the heterozygous genotypes
after irradiation where the combination of this damage
and the one induced by radiation may result in higher
degree genetic instability.
Considering the network of physical interactions
between active factors in living cells may help to explain
how it is that reduced levels of expression of a single
protein may have such a large effect in the system of
events which comprise the biology of the cell. Biological
networks are capable of self assembly and disassembly.
For example, many local networks may be assembled
only when they are needed - for instance after DNA
double-strand breaks are induced. The requirement for
assembly in response to an e v e n ta ta nu n k n o w np o i n t
in a relatively large (on molecular scale) area, introduces
spatial and quantitative limitations on the process. DNA
double-strand breaks are a local event that may appear
at any place in the nucleus. A local network has to be
assembled at the points of DNA double-strand breaks in
order to signal and initiate the repair. Proteins, potential
members of the local networks, have to be in close
proximity to the break or to be able to translocate
quickly to the site. Several experiments confirmed that
this is the case. Immunofluorescence analysis of cells
after radiation induced DNA double-strand breaks show
that many DNA repair proteins, like ATM, P53BP1,
M R E 1 1 ,R a d 5 0a n dN B S 1 ,A T R ,c o l o c a l i z ea n df o r m
discrete foci on the sites of DNA damage [36,37]. In
addition, migration of DNA repair proteins toward the
site of DNA damage has been analyzed by FRAP. By
Figure 3 CD4
+ CD8
+ cell survival after g-ray irradiation. A) CD4
+ CD8
+ cell survival after g-ray irradiation. Cell survival was highest (apoptosis
was lowest) in the double hemizygous background. In contrast the percent of CD4
+ CD8
+ cells does not depend of the genotype in
nonirradiated cells. The numbers of mice used was three per genotype for the controls and five per genotype for the irradiated mice. B)
Representative image of flow cytometry of the thymocytes. Top panel: Atmwt/Brca1wt genotype. CD4
+ CD8
+ cells appear at the upper right
quadrant and are 31% of the total cell numbers. Note also the very low numbers of CD4
+ and CD8
+ cells which appear in the lower right and
upper left quadrants. Lower panel represents Atmhz/Brca1hz genotype where 61% of the double positive CD4
+ CD8
+ cells survived accompanied
also with high numbers of CD4
+ and CD8
+ cells (lower left and upper right quadrants).
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teins it has been shown that translocation and transient
immobilization of RAD51, RAD52, RAD54 as well as
the NER repair complex ERCC1-XPF and P53BP1
[38-40] occurs at DNA repair sites in mammalian cells.
In the case of multiple DNA dsb, haploinsufficiency for
ATM or BRCA1 may lead to incomplete assembly of
the repair complex. As a result, some DNA dsb may not
be detected or repaired and the cells will not fail to cor-
rectly undergo apoptosis. In this way, the failure of local
networks could lead to the accrual of mutations in living
cells.
Conclusions
In summary, we have shown that hemizygosity and
combined hemizygosity for Atm and BRCA1 both con-
stitute a prominent contribution to radiation induced
cell transformation and apoptosis. While it has long
been hypothesized that radiosensitivity in some indivi-
duals may well be the result of haploinsufficiency for
low penetrance genes, little progress has been made in
elucidating specific examples. We have now identified
three genes with high penetrance and a low frequency
of mutation that confer sensitivity to radiation induced
effects, such as cancer. This is relevant given that the
frequency of mutation of any individual sensitizing gene
inducing heterozygosity among individuals in the gen-
eral human population may be low and largely unde-
tected. Compound heritable mutations inducing
heterozygosity in more than one radio sensitizing gene
could render a sub-population particularly radiosensi-
tive. Since such heritable mutations can become concen-
trated in certain ethnic groups, elements of the human
p o p u l a t i o nm a yb ee s p e c i a l l yv u l n e r a b l et or a d i a t i o n
induced biological effects.
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